Aegis Vopak Terminals has released its monitoring agency report for the quarter ending December 31, 2025 (Q3 2026). The report, prepared by CARE Ratings, indicates that issue proceeds from the IPO have been utilized as disclosed in the offer documents. There were no major deviations observed in the quarter. A small portion of funds remains unutilized, deployed in a monitoring account.
IPO Proceeds Utilization
Aegis Vopak Terminals confirms the appropriate utilization of funds raised through its Initial Public Offering (IPO). As of December 31, 2025, the monitoring agency, CARE Ratings, has reported that the proceeds have been applied in line with the objectives outlined in the original offer document.
Key Financial Data & Utilization Details
The total IPO issue size was ₹2,800 crore. Here’s a breakdown of how these funds have been allocated:
- Repayment/prepayment of borrowings: ₹2,015.95 crore
- Funding capital expenditure: ₹671.30 crore
- General Corporate Purposes: ₹5.00 crore
- Offer Related Expenses: ₹105.70 crore
Unutilized Funds
A small balance of ₹2.05 crore remains unutilized and is currently deployed in a monitoring account. No funds were utilized during Q3 2026 toward the object of the issue.
No Major Deviations
The monitoring agency has not identified any major deviations from the intended use of funds as specified in the offer documents. All governmental and statutory approvals related to the object(s) have been obtained.
Source: BSE
